ANI Pharmaceuticals (ANIP)

[Just the facts maam]

I find it interesting that Unimed (AbbVie subsidiary) and Besins have two patent applications that were abandonned for failure to respond to office action. These patent application were the latest version in a series of continuations of previous patent applications. Just like Libigel related patent applications they did did not respond and did not file a new continuing patent application.

TESTOSTERONE GEL AND METHOD OF USE on 06-19-2017

ANDROGEN PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING DEPRESSION on 11-28-2016

With Androgel sales droping out of sight one could of assumed they were walking away from Testosterone. However, the two phase 4 testosterone trials sponsored by AbbVie with a combined 6190 participants indicates otherwise.

And with the renewed focus of female testosterone, it will be interesting to see if Libigel and Androgel related patent applications are filed as continuations at least in-part of the abandonned applications. If so, we may see supporting evidence for the Breast Cancer event reduction claim.